ReviewFrontiers in immunology2026
Multi-omics biomarkers for predicting resistance, hyperprogression, and immune-related toxicity during PD-1/PD-L1 therapy in lung cancer: a literature review.
Na Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.